Cardiac remodeling at the population level-risk factors, screening, and outcomes

Nature Reviews Cardiology

Volumn 8, Issue 12, 2011, Pages 673-685

  Gjesdal, Ola ^a   Bluemke, David A ^b   Lima, Joao A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BODY BUILD; BODY HEIGHT; BODY WEIGHT; CARDIAC PATIENT; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ETHNICITY; EXTRACELLULAR MATRIX; FIBROBLAST; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE REMODELING; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; LIFESTYLE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SCREENING; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; EARLY DIAGNOSIS; FEMALE; HEART FAILURE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; VENTRICULAR REMODELING;

EID: 82255192327     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2011.154     Document Type: Review

References (135)

1. Cohn, J. N., Ferrari, R. & Sharpe, N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J. Am. Coll. Cardiol. 35, 569-582 (2000). (Pubitemid 30167013)
2. Gardin, J. M. et al. M-mode echocardiographic predictors of six-to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am. J. Cardiol. 87, 1051-1057 (2001). (Pubitemid 32710318)
3. Kannel, W. B. Hazards, risks, and threats of heart disease from the early stages to symptomatic coronary heart disease and cardiac failure. Cardiovasc. Drugs and Ther. 11, 199-212 (1997). (Pubitemid 27229315)
4. Hill, A. B. The environment and disease: association or causation? Proc. R. Soc. Med. 58, 295-300 (1965).
5. Lang, R. M. et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 18, 1440-1463 (2005). (Pubitemid 41821197)
6. Rodriguez, C. J. et al. Left ventricular mass and ventricular remodeling among Hispanic subgroups compared with non-Hispanic blacks and whites: MESA (Multi-ethnic Study of Atherosclerosis). J. Am. Coll. Cardiol. 55, 234-242 (2010).
7. Bluemke, D. A. et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J. Am. Coll. Cardiol. 52, 2148-2155 (2008).
8. Kawut, S. M. et al. Sex and race differences in right ventricular structure and function: the multi-ethnic study of atherosclerosis-right ventricle study. Circulation 123, 2542-2551 (2011).
9. Gidding, S. S. et al. Low cardiovascular risk is associated with favorable left ventricular mass, left ventricular relative wall thickness, and left atrial size: The CARDIA study. J. Am. Soc. Echocardiogr. 23, 816-822 (2010).
10. Harvey, W. Exercitatio anatomica de motu cordis et sanguinis in animalibus (1628).
11. Katz, A. M. Maladaptive growth in the failing heart: the cardiomyopathy of overload. Cardiovasc. Drugs Ther. 16, 245-249 (2002). (Pubitemid 35398626)
12. Fulton R. M., Hutchinson, E. C. & Jones, M. A. Ventricular weight in cardiac hypertrophy. Br. Heart J. 14, 413-420 (1952).
13. Katz, A. M. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N. Engl. J. Med 322, 100-110 (1990). (Pubitemid 20023868)
14. Heineke, J. & Molkentin, J. D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 7, 589-600 (2006). (Pubitemid 44325350)
15. van den Borne, S. W. et al. Myocardial remodeling after infarction: the role of myofibroblasts. Nat. Rev. Cardiol. 7, 30-37 (2010).
16. Grossman, W., Jones, D. & McLaurin, L. P. Wall stress and patterns of hypertrophy in the human left ventricle. J. Clin. Invest 56, 56-64 (1975).
17. Lorell, B. H. & Carabello, B. A. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102, 470-479 (2000). (Pubitemid 30490688)
18. Levy, D., Larson, M. G., Vasan, R. S., Kannel, W. B. & Ho, K. K. The progression from hypertension to congestive heart failure. JAMA 275, 1557-1562 (1996). (Pubitemid 26154241)
19. Konstam, M. A., Kramer, D. G., Patel, A. R., Maron, M. S. & Udelson, J. E. Left ventricular remodeling in heart failure current concepts in clinical significance and assessment. JACC Cardiovasc. Imaging 4, 98-108 (2011).
20. Gajarsa, J. J. & Kloner, R. A. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail. Rev. 16, 13-21 (2011).
21. Mewton, N., Liu, C. Y., Croisille, P., Bluemke, D. & Lima, J. A. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 57, 891-903 (2011).
22. Klem, I. & Kim, R. J. Assessment of microvascular injury after acute myocardial infarction: importance of the area at risk. Nat. Clin. Pract. Cardiovasc. Med. 5, 756-757 (2008).
23. Wu, K. C. & Lima, J. A. Noninvasive imaging of myocardial viability: current techniques and future developments. Circ. Res. 93, 1146-1158 (2003). (Pubitemid 37543055)
24. Yu, C. M. et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 105, 438-445 (2002).
25. St John Sutton, M. G. et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107, 1985-1990 (2003). (Pubitemid 36506071)
26. Groenning, B. A. et al. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J. Am. Coll. Cardiol. 36, 2072-2080 (2000).
27. Chan, A. K. et al. Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure. J. Am. Coll. Cardiol. 50, 591-596 (2007). (Pubitemid 47199012)
28. Doughty, R. N., Whalley, G. A., Gamble, G., MacMahon, S. & Sharpe, N. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. J. Am. Coll. Cardiol. 29, 1060-1066 (1997). (Pubitemid 27149582)
29. Mor-Avi, V. et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur. J. Echocardiogr. 12, 167-205 (2011).
30. Bursi, F. et al. Systolic and diastolic heart failure in the community. JAMA 296, 2209-2216 (2006). (Pubitemid 44708051)
31. Gardin, J. M. et al. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study. Circulation 91, 1739-1748 (1995).
32. Gardin, J. M. et al. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Circulation 92, 380-387 (1995).
33. Drazner, M. H. et al. Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension 46, 124-129 (2005). (Pubitemid 40946502)
34. Jain, A. et al. Cardiovascular imaging for assessing cardiovascular risk in asymptomatic men versus women: the multi-ethnic study of atherosclerosis (MESA). Circ. Cardiovasc. Imaging 4, 8-15 (2011).
35. Salton, C. J. et al. Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort. J. Am. Coll. Cardiol. 39, 1055-1060 (2002). (Pubitemid 34234130)
36. Cheng, S. et al. Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis. Circ. Cardiovasc. Imaging 2, 191-198 (2009).
37. Natori, S. et al. Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity. AJR Am. J. Roentgenol. 186 (Suppl. 2), S357-S365 (2006). (Pubitemid 46105405)
38. Olivetti, G., Melissari, M., Capasso, J. M. & Anversa, P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ. Res. 68, 1560-1568 (1991).
39. Savage, D. D., Levy, D., Dannenberg, A. L., Garrison, R. J. & Castelli, W. P. Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (the Framingham Study). Am. J. Cardiol. 65, 371-376 (1990). (Pubitemid 20038922)
40. Lindroos, M., Kupari, M., Heikkila, J. & Tilvis, R. Predictors of left ventricular mass in old age: an echocardiographic, clinical and biochemical investigation of a random population sample. Eur. Heart J. 15, 769-780 (1994). (Pubitemid 24205966)
41. De Simone, G. et al. Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study. J. Hypertens. 20, 323-331 (2002). (Pubitemid 34913799)
42. Desai, R. V. et al. Natural history of concentric left ventricular geometry in community-dwelling older adults without heart failure during seven years of follow-up. Am. J. Cardiol. 107, 321-324 (2011).
43. Lindroos, M., Kupari, M., Heikkila, J. & Tilvis, R. Echocardiographic evidence of left ventricular hypertrophy in a general aged population. Am. J. Cardiol. 74, 385-390 (1994). (Pubitemid 24253478)
44. Ganau, A. et al. Ageing induces left ventricular concentric remodelling in normotensive subjects. J. Hypertens. 13, 1818-1822 (1995). (Pubitemid 26015824)
45. Lieb, W. et al. Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short-and long-term change in the Framingham offspring study. Circulation 119, 3085-3092 (2009).
46. Cheng, S. et al. Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study. Circulation 122, 570-578 (2010).
47. Lam, C. S. et al. Familial aggregation of left ventricular geometry and association with parental heart failure: the Framingham Heart Study. Circ. Cardiovasc. Genet. 3, 492-498 (2010).
48. Bella, J. N. et al. Heritability of left ventricular dimensions and mass in American Indians: The Strong Heart Study. J. Hypertens. 22, 281-286 (2004). (Pubitemid 38250986)
49. Morita, H. et al. Single-gene mutations and increased left ventricular wall thickness in the community. Circulation 113, 2697-2705 (2006). (Pubitemid 43947987)
50. O'Donnell, C. J. & Nabel, E. G. Cardiovascular genomics, personalized medicine, and the National Heart, Lung, and Blood Institute: part I: the beginning of an era. Circ. Cardiovasc. Genet. 1, 51-57 (2008).
51. Lauer, M. S., Anderson, K. M., Kannel, W. B. & Levy, D. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 266, 231-236 (1991).
52. Chinali, M. et al. Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J. Am. Coll. Cardiol. 47, 2267-2273 (2006). (Pubitemid 43795058)
53. Turkbey, E. B. et al. The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). JACC Cardiovasc. Imaging 3, 266-274 (2010).
54. Chirinos, J. A. et al. Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension 56, 91-98 (2010).
55. De Simone, G. et al. Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension 31, 1077-1082 (1998). (Pubitemid 28191500)
56. De Simone, G. et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J. Am. Coll. Cardiol. 20, 1251-1260 (1992).
57. Gidding, S. S. et al. Cardiac function in smokers and nonsmokers: the CARDIA study. The Coronary Artery Risk Development in Young Adults Study. J. Am. Coll. Cardiol. 26, 211-216 (1995).
58. Gardin, J. M. et al. Left ventricular mass in the elderly. The Cardiovascular Health Study. Hypertension 29, 1095-1103 (1997). (Pubitemid 27198216)
59. Heckbert, S. R. et al. Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis. J. Am. Coll. Cardiol. 48, 2285-2292 (2006). (Pubitemid 44855426)
60. Basavarajaiah, S. et al. Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 51, 2256-2262 (2008). (Pubitemid 351754996)
61. Turkbey, E. B. et al. Physical activity and physiological cardiac remodelling in a community setting: the Multi-Ethnic Study of Atherosclerosis (MESA). Heart 96, 42-48 (2010).
62. Rodriguez, C. J. et al. Association between social isolation and left ventricular mass. Am. J. Med. 124, 164-170 (2011).
63. Cohn, J. N. Pharmacotherapy: inhibiting LV remodeling-the need for a targeted approach. Nat. Rev. Cardiol. 8, 248-249 (2011).
64. Weisman, H. F., Bush, D. E., Mannisi, J. A., Weisfeldt, M. L. & Healy, B. Cellular mechanisms of myocardial infarct expansion. Circulation 78, 186-201 (1988).
65. Kramer, C. M. et al. Regional differences in function within noninfarcted myocardium during left ventricular remodeling. Circulation 88, 1279-1288 (1993). (Pubitemid 23264049)
66. Mckay, R. G. et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation 74, 693-702 (1986). (Pubitemid 16007186)
67. Chareonthaitawee, P., Christian, T. F., Hirose, K., Gibbons, R. J. & Rumberger, J. A. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J. Am. Coll. Cardiol. 25, 567-573 (1995).
68. van Gilst, W. H., Kingma, J. H., Peels, K. H., Dambrink, J. H. & St John, S. M. Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS). J. Am. Coll. Cardiol. 28, 114-121 (1996). (Pubitemid 26266630)
69. Pfeffer, M. A. & Braunwald, E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81, 1161-1172 (1990). (Pubitemid 20119612)
70. Orn, S. et al. Effect of left ventricular scar size, location, and transmurality on left ventricular remodeling with healed myocardial infarction. Am. J. Cardiol. 99, 1109-1114 (2007). (Pubitemid 46560460)
71. Verma, A. et al. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (valsartan in acute myocardial infarction) Echocardiographic Study. JACC Cardiovasc. Imaging 1, 582-591 (2008).
72. Bonow, R. O. et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118, e523-e661 (2008).
73. Gopinathannair, R., Sullivan, R. & Olshansky, B. Tachycardia-mediated cardiomyopathy: recognition and management. Curr. Heart Fail. Rep. 6, 257-264 (2009).
74. Dhingra, R. et al. Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensions: the Framingham Heart Study. J. Am. Coll. Cardiol. 45, 685-689 (2005). (Pubitemid 40278966)
75. Vernooy, K., Verbeek, X. A., Peschar, M. & Prinzen, F. W. Relation between abnormal ventricular impulse conduction and heart failure. J. Interv. Cardiol. 16, 557-562 (2003). (Pubitemid 37431024)
76. Roman, M. J. et al. Relations of central and brachial blood pressure to left ventricular hypertrophy and geometry: the Strong Heart Study. J. Hypertension 28, 384-388 (2010).
77. Palmieri, V. et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation 103, 102-107 (2001). (Pubitemid 32050443)
78. Bella, J. N. et al. Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am. J. Cardiol. 87, 1260-1265 (2001). (Pubitemid 32493866)
79. Velagaleti, R. S. et al. Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study. Circ. Cardiovasc. Imaging 3, 257-263 (2010).
80. Eguchi, K. et al. Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population. Am. J. Cardiol. 101, 1787-1791 (2008).
81. Cerasola, G. et al. Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function. Nephrology (Carlton.) 15, 203-210 (2010).
82. Patel, P. C. et al. Association of cystatin C with left ventricular structure and function: the Dallas Heart Study. Circ. Heart Fail. 2, 98-104 (2009).
83. Nasir, K. et al. Regional left ventricular function in individuals with mild to moderate renal insufficiency: the Multi-Ethnic Study of Atherosclerosis. Am. Heart J. 153, 545-551 (2007). (Pubitemid 46440695)
84. Jullien, V., Gosse, P., Ansoborlo, P., Lemetayer, P. & Clementy, J. Relationship between left ventricular mass and serum cholesterol level in the untreated hypertensive. J. Hypertension 16, 1043-1047 (1998). (Pubitemid 28367960)
85. Horio, T., Miyazato, J., Kamide, K., Takiuchi, S. & Kawano, Y. Influence of low high-density lipoprotein cholesterol on left ventricular hypertrophy and diastolic function in essential hypertension. Am. J. Hypertens. 16, 938-944 (2003). (Pubitemid 37315493)
86. Celentano, A. et al. Left ventricular geometry and arterial function in hypercholesterolemia. Nutr. Metab. Cardiovasc. Dis. 11, 312-319 (2001). (Pubitemid 33687820)
87. Velagaleti, R. S. et al. Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study. Circulation 120, 2345-2351 (2009).
88. Chinali, M. et al. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am. J. Cardiol. 93, 40-44 (2004). (Pubitemid 38028620)
89. Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B. & Castelli, W. P. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann. Intern. Med. 110, 101-107 (1989). (Pubitemid 19033194)
90. Levy, D., Salomon, M., D'Agostino, R. B., Belanger, A. J. & Kannel, W. B. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 90, 1786-1793 (1994). (Pubitemid 24320926)
91. Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B. & Castelli, W. P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322, 1561-1566 (1990). (Pubitemid 20176696)
92. Haider, A. W., Larson, M. G., Benjamin, E. J. & Levy, D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J. Am. Coll. Cardiol. 32, 1454-1459 (1998). (Pubitemid 28522409)
93. Gottdiener, J. S. et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J. Am. Coll. Cardiol. 35, 1628-1637 (2000). (Pubitemid 30307510)
94. De Simone, G., Gottdiener, J. S., Chinali, M. & Maurer, M. S. Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. Eur. Heart J. 29, 741-747 (2008). (Pubitemid 351431013)
95. Devereux, R. B. et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am. J. Cardiol. 86, 1090-1096 (2000).
96. De Simone, G. et al. Left ventricular mass and incident hypertension in individuals with initial optimal blood pressure: the Strong Heart Study. J. Hypertension 26, 1868-1874 (2008).
97. Mazza, A., Tikhonoff, V., Casiglia, E. & Pessina, A. C. Predictors of congestive heart failure mortality in elderly people from the general population. Int. Heart J. 46, 419-431 (2005).
98. Krumholz, H. M., Larson, M. & Levy, D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J. Am. Coll. Cardiol. 25, 879-884 (1995).
99. Koren, M. J., Devereux, R. B., Casale, P. N., Savage, D. D. & Laragh, J. H. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann. Intern. Med. 114, 345-352 (1991).
100. Ghali, J. K., Liao, Y. & Cooper, R. S. Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J. Am. Coll. Cardiol. 31, 1635-1640 (1998). (Pubitemid 28273309)
101. Di Tullio, M. R., Zwas, D. R., Sacco, R. L., Sciacca, R. R. & Homma, S. Left ventricular mass and geometry and the risk of ischemic stroke. Stroke 34, 2380-2384 (2003). (Pubitemid 37221946)
102. Verdecchia, P. et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J. Am. Coll. Cardiol. 25, 871-878 (1995).
103. Drazner, M. H. et al. Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. J. Am. Coll. Cardiol. 43, 2207-2215 (2004). (Pubitemid 38757586)
104. Fernandes, V. R. S. et al. The influence of left ventricular size and global function on regional myocardial contraction and relaxation in an adult population free of cardiovascular disease: a tagged CMR study of the MESA cohort. J. Cardiovasc. Magn. Reson. 9, 921-930 (2007). (Pubitemid 350232932)
105. Rosen, B. D. et al. Left ventricular concentric remodeling is associated with decreased global and regional systolic function: the Multi-Ethnic Study of Atherosclerosis. Circulation 112, 984-991 (2005). (Pubitemid 41170266)
106. Devereux, R. B. et al. A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study. Am. Heart J. 141, 439-446 (2001). (Pubitemid 32200274)
107. Kannel, W. B. et al. Profile for estimating risk of heart failure. Arch. Intern. Med 159, 1197-1204 (1999). (Pubitemid 29269859)
108. Butler, J. et al. Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ. Heart Fail. 1, 125-133 (2008).
109. Gupta, S. et al. Association of Health Aging and Body Composition (ABC) Heart Failure score with cardiac structural and functional abnormalities in young individuals. Am. Heart J. 159, 817-824 (2010).
110. Hunt, S. A. et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J. Am. Coll. Cardiol. 38, 2101-2113 (2001). (Pubitemid 33116591)
111. Cheitlin, M. D. et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 108, 1146-1162 (2003). (Pubitemid 37074844)
112. Shapiro, E. P. et al. Determination of left ventricular mass by magnetic resonance imaging in hearts deformed by acute infarction. Circulation 79, 706-711 (1989). (Pubitemid 19087722)
113. Devereux, R. B. et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol. 57, 450-458 (1986). (Pubitemid 16119719)
114. Gottdiener, J. S., Livengood, S. V., Meyer, P. S. & Chase, G. A. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. J. Am. Coll. Cardiol. 25, 424-430 (1995).
115. Myerson, S. G., Bellenger, N. G. & Pennell, D. J. Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension 39, 750-755 (2002). (Pubitemid 34252869)
116. Dickstein, K. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J. 29, 2388-2442 (2008).
117. Grothues, F. et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am. J. Cardiol. 90, 29-34 (2002). (Pubitemid 34671198)
118. Bellenger, N. G., Davies, L. C., Francis, J. M., Coats, A. J. & Pennell, D. J. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson. 2, 271-278 (2000). (Pubitemid 32048395)
119. Kannel, W. B., Gordon, T., Castelli, W. P. & Margolis, J. R. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann. Intern. Med. 72, 813-822 (1970).
120. Devereux, R. B. & Reichek, N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55, 613-618 (1977). (Pubitemid 8066109)
121. Jain, A. et al. Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA). Am. Heart J. 159, 652-658 (2010).
122. Kannel, W. B. & Cobb, J. Left ventricular hypertrophy and mortality-results from the Framingham Study. Cardiology 81, 291-298 (1992). (Pubitemid 23113884)
123. Carr, A. A., Prisant, L. M. & Watkins, L. O. Detection of hypertensive left ventricular hypertrophy. Hypertension 7, 948-954 (1985). (Pubitemid 16147477)
124. Nasir, K. et al. Comparison of left ventricular size by computed tomography with magnetic resonance imaging measures of left ventricle mass and volumes: the multi-ethnic study of atherosclerosis. J. Cardiovasc. Comput. Tomogr. 2, 141-148 (2008).
125. Sigurdsson, G. CT for assessing ventricular remodeling: is it ready for prime time? Curr. Heart Fail. Rep. 5, 16-22 (2008).
126. Redfield, M. M. et al. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation 109, 3176-3181 (2004).
127. Vasan, R. S. et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 288, 1252-1259 (2002). (Pubitemid 35001328)
128. Lee, D. S., Wang, T. J. & Ramachandran, V. S. Screening for Ventricular Remodeling. Curr. Heart Fail. Rep. 3, 5-13 (2006). (Pubitemid 44623911)
129. Prasad, S. K. et al. Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study. Heart 92, 798-803 (2006). (Pubitemid 43799215)
130. Devereux, R. B. et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 292, 2350-2356 (2004). (Pubitemid 39491919)
131. Verdecchia, P. et al. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy? J. Hum. Hypertens. 18 (Suppl. 2), S23-S28 (2004).
132. Chung, E. S. et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation 117, 2608-2616 (2008).
133. Merlo, M. et al. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J. Am. Coll. Cardiol. 57, 1468-1476 (2011).
134. Burkhoff, D., Klotz, S. & Mancini, D. M. LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery. J. Card. Fail. 12, 227-239 (2006).
135. Krayenbuehl, H. P. et al. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 79, 744-755 (1989). (Pubitemid 19100533)